Aggressive uveal melanoma displays a high degree of centrosome amplification, opening the door to therapeutic intervention.

ABSTRACT: Uveal melanoma (UM) is the most common intraocular cancer in adults. Whilst treatment of primary UM (PUM) is often successful, around 50% of patients develop metastatic disease with poor outcomes, linked to chromosome 3 loss (monosomy 3, M3). Advances in understanding UM cell biology may indicate new therapeutic options. We report that UM exhibits centrosome abnormalities, which in other cancers are associated with increased invasiveness and worse prognosis, but also represent a potential Achilles' heel for cancer-specific therapeutics. Analysis of 75 PUM patient samples revealed both higher centrosome numbers and an increase in centrosomes with enlarged pericentriolar matrix (PCM) compared to surrounding normal tissue, both indicative of centrosome amplification. The PCM phenotype was sig

SUBMITTER: Sabat-Pospiech D 

PROVIDER: S-EPMC9161346 | biostudies-literature | 2022 Jul

REPOSITORIES: biostudies-literature